Compare · CARL vs WST
CARL vs WST
Side-by-side comparison of Carlsmed Inc. (CARL) and West Pharmaceutical Services Inc. (WST): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CARL and WST operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- WST is the larger of the two at $28.85B, about 59.3x CARL ($486.1M).
- CARL has been more active in the news (7 items in the past 4 weeks vs 6 for WST).
- WST has more recent analyst coverage (20 ratings vs 6 for CARL).
- Company
- Carlsmed Inc.
- West Pharmaceutical Services Inc.
- Price
- -
- -
- Market cap
- $486.1M
- $28.85B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 7
- 6
- Recent ratings
- 6
- 20
West Pharmaceutical Services Inc.
West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Latest CARL
- Carlsmed to Participate in Upcoming Investor Conferences
- SEC Form 10-Q filed by Carlsmed Inc.
- Carlsmed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Carlsmed® Reports Third Quarter 2026 Financial Results and Raises Full-Year Guidance
- Chief Operating Officer Bertolini Jeffrey exercised 747 shares at a strike of $5.92 and sold $11,317 worth of shares (747 units at $15.15) as part of a pre-agreed trading plan (SEC Form 4)
- Chief Operating Officer Bertolini Jeffrey exercised 243 shares at a strike of $2.23 and sold $3,839 worth of shares (243 units at $15.80) as part of a pre-agreed trading plan (SEC Form 4)
- Carlsmed, Inc. to Report Third Quarter 2026 Financial Results on November 10, 2026
- SEC Form 144 filed by Carlsmed Inc.
- Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System
- Chief Operating Officer Bertolini Jeffrey sold $10,749 worth of shares (747 units at $14.39) as part of a pre-agreed trading plan (SEC Form 4)
Latest WST
- Amendment: SEC Form SCHEDULE 13G/A filed by West Pharmaceutical Services Inc.
- West to Participate in Upcoming Investor Conference
- SEC Form 10-Q filed by West Pharmaceutical Services Inc.
- SEC Form 8-K filed by West Pharmaceutical Services Inc.
- West Reports Third-Quarter 2026 Results
- SEC Form 8-K filed by West Pharmaceutical Services Inc.
- West Declares Quarterly Dividend
- West to Host Third-Quarter 2026 Conference Call
- West to Highlight Industry Leadership in Packaging and Containment at CPHI Worldwide
- SEC Form 4 filed by Director Haugen Janet Brutschea